|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bergengren O, Pekala KR, Matsoukas K,
Fainberg J, Mungovan SF, Bratt O, Bray F, Brawley O, Luckenbaugh
AN, Mucci L, et al: 2022 update on prostate cancer epidemiology and
risk Factors-A systematic review. Eur Urol. 84:191–206. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Merkens L, Sailer V, Lessel D, Janzen E,
Greimeier S, Kirfel J, Perner S, Pantel K, Werner S and von Amsberg
G: Aggressive variants of prostate cancer: Underlying mechanisms of
neuroendocrine transdifferentiation. J Exp Clin Cancer Res.
41:462022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gupta K and Gupta S: Neuroendocrine
differentiation in prostate cancer: Key epigenetic players. Transl
Cancer Res. 6 (Suppl 1):S104–S108. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hu CD, Choo R and Huang J: Neuroendocrine
differentiation in prostate cancer: A mechanism of radioresistance
and treatment failure. Front Oncol. 5:902015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ejaz S, Vassilopoulou-Sellin R, Busaidy
NL, Hu MI, Waguespack SG, Jimenez C, Ying AK, Cabanillas M, Abbara
M and Habra MA: Cushing's syndrome secondary to ectopic ACTH
secretion: The University of Texas MD Anderson Cancer Center
Experience. Cancer. 117:4381–4389. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Matzkin H and Braf Z: Paraneoplastic
syndromes associated with prostatic carcinoma. J Urol.
138:1129–1133. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dhom G: Unusual prostatic carcinomas.
Pathol Res Pract. 186:28–36. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yonaha M, Tanaka M, Kawano T, Sugiyama M,
Nishikawa T and Sasano K: An autopsy case of ACTH producing
prostate neoplasms with Cushing's syndrome. Nihon Naika Gakkai
Zasshi. 81:2005–2006. 1992.(In Japanese). View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ciudin A, Huguet Perez J, Ribal Caparros
MJ and Alcaraz Asensio A: Cushing syndrome and prostate cancer
recurrence with undetectable prostate-specific antigen. Med Clin
(Barc). 140:430–431. 2013.(In Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wenk RE, Bhagavan BS, Levy R, Miller D and
Weisburger W: Ectopic ACTH, prostatic oat cell carcinoma, and
marked hypernatremia. Cancer. 40:773–778. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vuitch MF and Mendelsohn G: Relationship
of ectopic ACTH production to tumor differentiation: A morphologic
and immunohistochemical study of prostatic carcinoma with Cushing's
syndrome. Cancer. 47:296–299. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Carey RM, Varma SK, Drake CR, Thorner MO,
Kovacs K, Rivier J and Vale W: Ectopic secretion of
corticotropin-releasing factor as a cause of Cushing's syndrome. A
clinical, morphologic, and biochemical study. N Engl J Med.
311:13–20. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fjellestad-Paulsen A, Abrahamsson PA,
Bjartell A, Grino M, Grimelius L, Hedeland H and Falkmer S:
Carcinoma of the prostate with Cushing's syndrome. A case report
with histochemical and chemical demonstration of immunoreactive
corticotropin-releasing hormone in plasma and tumoral tissue. Acta
Endocrinol (Copenh). 119:506–516. 1988.PubMed/NCBI
|
|
15
|
Haukaas SA, Halvorsen OJ, Nygaard SJT and
Paus E: Cushing's syndrome in prostate cancer. An aggressive course
of prostatic malignancy. Urol Int. 63:126–129. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rickman T, Garmany R, Doherty T, Benson D
and Okusa MD: Hypokalemia, metabolic alkalosis, and hypertension:
Cushing's syndrome in a patient with metastatic prostate
adenocarcinoma. Am J Kidney Dis. 37:838–846. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Johnson TN and Canada TW: Etomidate use
for Cushing's syndrome caused by an ectopic adrenocorticotropic
hormone-producing tumor. Ann Pharmacother. 41:350–353. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kataoka K, Akasaka Y, Nakajima K, Nagao K,
Hara H, Miura K and Ishii N: Cushing syndrome associated with
prostatic tumor adrenocorticotropic hormone (ACTH) expression after
maximal androgen blockade therapy. Int J Urol. 14:436–439. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nimalasena S, Freeman A and Harland S:
Paraneoplastic Cushing's syndrome in prostate cancer: A difficult
management problem. BJU Int. 101:424–427. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Alwani RA, Neggers SJ, van der Klift M,
Baggen MG, van Leenders GJ, van Aken MO, van der Lely AJ, de Herder
WW and Feelders RA: Cushing's syndrome due to ectopic ACTH
production by (neuroendocrine) prostate carcinoma. Pituitary.
12:280–283. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rajec J, Mego M, Sycova-Mila Z, Obertova
J, Brozmanova K and Mardiak J: Paraneoplastic Cushing's syndrome as
the first sign of progression of prostate cancer. Bratisl Lek
Listy. 109:362–363. 2008.PubMed/NCBI
|
|
22
|
Alshaikh OM, Al-Mahfouz AA, Al-Hindi H,
Mahfouz AB and Alzahrani AS: Unusual cause of ectopic secretion of
adrenocorticotropic hormone: Cushing syndrome attributable to small
cell prostate cancer. Endocr Pract. 16:249–254. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ramon I, Kleynen P, Valsamis J, Body JJ
and Karmali R: Hypophosphatemia related to paraneoplastic Cushing
syndrome in prostate cancer: Cure after bilateral adrenalectomy.
Calcif Tissue Int. 89:442–445. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rueda-Camino JA, Losada-Vila B, De
Ancos-Aracil CL, Rodríguez-Lajusticia L, Tardío JC and
Zapatero-Gaviria A: Small cell carcinoma of the prostate presenting
with Cushing Syndrome. A narrative review of an uncommon condition.
Ann Med. 48:293–299. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shrosbree J, Pokorny A, Stone E, Epstein
R, Mccormack A and Greenfield JR: Ectopic Cushing syndrome due to
neuroendocrine prostatic cancer. Intern Med J. 46:630–632. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ramalingam S, Eisenberg A, Foo WC,
Freedman J, Armstrong AJ, Moss LG and Harrison MR:
Treatment-related neuroendocrine prostate cancer resulting in
Cushing's syndrome. Int J Urol. 23:1038–1041. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Elston MS, Crawford VB, Swarbrick M, Dray
MS, Head M and Conaglen JV: Severe Cushing's syndrome due to small
cell prostate carcinoma: A case and review of literature. Endocr
Connect. 6:R80–R86. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Murphy N, Shen J, Shih A, Liew A, Khalili
H, Yaskiv O, Katona K, Lee A and Zhu XH: Paraneoplastic syndrome
secondary to treatment emergent neuroendocrine tumor in metastatic
Castration-resistant prostate cancer: A unique case. Clin
Genitourin Cancer. 17:e56–e60. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kleinig P and Russell P: Lesson of the
month 2: An unusual cause of depression in an older man: Cushing's
syndrome resulting from metastatic small cell cancer of the
prostate. Clin Med (Lond). 18:432–434. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Klomjit N, Rowan DJ, Kattah AG, Bancos I
and Taler SJ: New-Onset resistant hypertension in a newly diagnosed
prostate cancer patient. Am J Hypertens. 32:1214–1217. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Soundarrajan M, Zelada H, Fischer JV and
Kopp P: Ectopic adrenocorticotropic hormone syndrome due to
metastatic prostate cancer with neuroendocrine differentiation.
AACE Clin Case Reports. 5:e192–e196. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schepers LM, Kisters JMH, Wetzels C and
Creemers GJ: Hypokalaemia and peripheral oedema in a Cushingoid
patient with metastatic prostate cancer. Neth J Med. 78:401–403.
2020.PubMed/NCBI
|
|
33
|
Riaza Montes M, Arredondo Calvo P and
Gallego Sánch JA: Small cell metastatic prostate cancer with
ectopic adrenocorticotropic hormone hypersecretion: A case report.
Ann Palliat Med. 10:12911–12914. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fernandes R, Dos Santos J, Reis F and
Monteiro S: Cushing syndrome as a manifestation of neuroendocrine
prostate cancer: A rare presentation within a rare tumor. Cureus.
13:e181602021.PubMed/NCBI
|
|
35
|
Zeng W and Khoo J: Challenging case of
ectopic ACTH secretion from prostate adenocarcinoma. Case Rep
Endocrinol. 2022:37399572022.PubMed/NCBI
|
|
36
|
Hassan B, Yazbeck Y, Akiki V, Salti I and
Tfayli A: ACTH-secreting metastatic prostate cancer with
neuroendocrine differentiation. BMJ Case Rep. 15:e2479972022.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Newmark SR, Dluhy RG and Bennett AH:
Ectopic adrenocorticotropin syndrome with prostatic carcinoma.
Urology. 2:666–668. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Webster GD Jr, Touchstone JC and Suzuki M:
Adrenocortical hyperplasia occurring with metastatic carcinoma of
the prostate: Report of a case exhibiting increased urinary
aldosterone and glucocorticoid excretion. J Clin Endocrinol Metab.
19:967–979. 1959. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lovern WJ, Fariss BL, Wettlaufer JN and
Hane S: Ectopic ACTH production in disseminated prostatic
adenocarcinoma. Urology. 5:817–820. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Slater D: Carcinoid tumour of the prostate
associated with inappropriate ACTH secretion. Br J Urol.
57:591–592. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Molland EA: Prostatic adenocarcinoma with
ectopic ACTH production. Br J Urol. 50:358. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wise HM, Pohl AL, Gazzaniga A and Harrison
JH: Hyperadrenocorticism associated with ‘reactivated’ prostatic
carcinoma. Surgery. 57:655–664. 1965.PubMed/NCBI
|
|
43
|
Ghali VS and Garcia RL: Prostatic
adenocarcinoma with carcinoidal features producing
adrenocorticotropic syndrome. Immunohistochemical study and review
of the literature. Cancer. 54:1043–1048. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hussein WI, Kowalyk S and Hoogwerf BJ:
Ectopic adrenocorticotropic hormone syndrome caused by metastatic
carcinoma of the prostate: Therapeutic response to ketoconazole.
Endocr Pract. 8:381–384. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Statham BN, Pardoe TH and Mir MA: Response
of ectopic prostatic ACTH production to metyrapone. Postgrad Med J.
57:467–468. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hall TC: Symptomatic hypokalemic alkalosis
in hyperadrenocorticism secondary to carcinoma of the prostate.
Cancer. 21:190–192. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Balestrieri A, Magnani E and Nuzzo F:
Unusual Cushing's syndrome and hypercalcitoninaemia due to a small
cell prostate carcinoma. Case Rep Endocrinol.
2016:63080582016.PubMed/NCBI
|
|
48
|
Asa SL, Kovacs K, Vale W, Petrusz P and
Vecsei P: Immunohistologic localization of corticotrophin-releasing
hormone in human tumors. Am J Clin Pathol. 87:327–333. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lemoinne S, Baudel JL, Galbois A,
Offenstadt G and Maury E: Suddzith Cushing's Syndrome. Open
Endocrinol J. 4:1–2. 2014. View Article : Google Scholar
|
|
50
|
Takeuchi M, Sato J, Manaka K, Tanaka M,
Matsui H, Sato Y, Kume H, Fukayama M, Iiri T, Nangaku M and Makita
N: Molecular analysis and literature-based hypothesis of an
immunonegative prostate small cell carcinoma causing ectopic ACTH
syndrome. Endocr J. 66:547–554. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Atmaca M, Temiz C, Sebile DH, Dökmetaș M
and Kiliçli F: A rare cause of ectopic cushing syndrome: Prostate
cancer. Endocr Abstr. 70:EP3482020.
|
|
52
|
Bloomer Z, Teague J and Vietor N: Ectopic
Cushing's From metastatic prostate cancer. J Endocr Soc.
5:A7572021. View Article : Google Scholar
|
|
53
|
Nadal R, Schweizer M, Kryvenko ON, Epstein
JI and Eisenberger MA: Small cell carcinoma of the prostate. Nat
Rev Urol. 1:213–219. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Rojas-Corona RR, Chen L and Mahadevia PS:
Prostatic carcinoma with endocrine features. A report of a neoplasm
containing multiple immunoreactive hormonal substances. Am J Clin
Pathol. 88:759–762. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Abrahamsson PA, Wadström LB, Alumets J,
Falkmer S and Grimelius L: Peptide-hormone- and
serotonin-immunoreactive tumour cells in carcinoma of the prostate.
Pathol Res Pract. 182:298–307. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Jarett L, Lacy PE and Kipnis DM:
Characterization by immunofluorescence of an Acth-like substance in
nonpituitary tumors from patients with hyperadrenocorticism. J Clin
Endocrinol Metab. 24:543–549. 1964. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Turbat-Herrera EA, Herrera GA, Gore I,
Lott RL, Grizzle WE and Bonnin JM: Neuroendocrine differentiation
in prostatic carcinomas. A retrospective autopsy study. Arch Pathol
Lab Med. 112:1100–1105. 1988.PubMed/NCBI
|
|
58
|
Capella C, Usellini L, Buffa R, Frigerio B
and Solcia E: The endocrine component of prostatic carcinomas,
mixed adenocarcinoma-carcinoid tumours and non-tumour prostate.
Histochemical and ultrastructural identification of the endocrine
cells. Histopathology. 5:175–192. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Shahani S, Nudelman RJ, Nalini R, Kim HS
and Samson SL: Ectopic corticotropin-releasing hormone (CRH)
syndrome from metastatic small cell carcinoma: A case report and
review of the literature. Diagn Pathol. 5:562010. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
di Sant'Agnese PA: Neuroendocrine
differentiation in carcinoma of the prostate diagnostic,
prognostic, and therapeutic implications. Cancer. 70 (1
Suppl):S254–S268. 1992. View Article : Google Scholar
|
|
61
|
Parimi V, Goyal R, Poropatich K and Yang
XJ: Neuroendocrine differentiation of prostate cancer: A review. Am
J Clin Exp Urol. 2:273–285. 2014.PubMed/NCBI
|
|
62
|
Hong MK, Kong J, Namdarian B, Longano A,
Grummet J, Hovens CM, Costello AJ and Corcoran NM: Paraneoplastic
syndromes in prostate cancer. Nat Rev Urol. 7:681–692. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Nadal R, Schweizer M, Kryvenko ON, Epstein
JI and Eisenberger MA: Small cell carcinoma of the prostate. Nat
Rev Urol. 11:213–219. 2014. View Article : Google Scholar : PubMed/NCBI
|
